Christopher Gibson, Director at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 67,265 shares at $3.46 ($234K) on 2026-02-19, disclosed to the SEC on 2026-02-19.
Seasonal sale ($234k) by Director — this insider has traded RXRX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.49 | 27,265 | $95K | 40.7% |
| 2 | $3.46 | 40,000 | $138K | 59.3% |
| Total | $3.47 avg | 67,265 | $234K | 100% |
| Filing → |
| RXRX | SELL | 2026-05-08 | $135K | — | Filing → |
| RXRX | SELL | 2026-04-24 | $144K | — | Filing → |
| RXRX | SELL | 2026-04-08 | $124K | — | Filing → |